154 related articles for article (PubMed ID: 8318274)
1. [Early gastric and superficial muscle gastric cancer. Contribution of morphology to prognosis].
Moral Moral G; Velasco Osés A; Seco Gil J; Bengoechea Beeby MP
Rev Esp Enferm Dig; 1993 May; 83(5):325-31. PubMed ID: 8318274
[TBL] [Abstract][Full Text] [Related]
2. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
3. Is tumor size a prognostic indicator for gastric carcinoma?
Yokota T; Ishiyama S; Saito T; Teshima S; Yamada Y; Iwamoto K; Takahashi M; Murata K; Yamauchi H
Anticancer Res; 2002; 22(6B):3673-7. PubMed ID: 12552975
[TBL] [Abstract][Full Text] [Related]
4. Significant prognostic factors in patients with early gastric cancer.
Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H
Int Surg; 2000; 85(4):286-90. PubMed ID: 11589593
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors for lymph node metastasis in early gastric cancer with submucosal invasion: analysis of a single institutional experience.
An JY; Baik YH; Choi MG; Noh JH; Sohn TS; Kim S
Ann Surg; 2007 Nov; 246(5):749-53. PubMed ID: 17968165
[TBL] [Abstract][Full Text] [Related]
6. Macroscopic tumor size as a simple prognostic indicator in patients with gastric cancer.
Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Oro S; Tatebe S; Tsujitani S; Ikeguchi M
Am J Surg; 2006 Sep; 192(3):296-300. PubMed ID: 16920421
[TBL] [Abstract][Full Text] [Related]
7. Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection.
Hanaoka N; Tanabe S; Mikami T; Okayasu I; Saigenji K
Endoscopy; 2009 May; 41(5):427-32. PubMed ID: 19418397
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic characteristics and surgical outcomes of mucinous gastric carcinoma.
Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono HA; Shimada H
Ann Surg Oncol; 2006 Jun; 13(6):836-42. PubMed ID: 16604474
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
[TBL] [Abstract][Full Text] [Related]
10. Gastric cancer with invasion limited to the muscularis propria.
Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Kikuchi S; Yamauchi H
Int Surg; 1999; 84(1):7-12. PubMed ID: 10421010
[TBL] [Abstract][Full Text] [Related]
11. Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type.
Adachi Y; Yasuda K; Inomata M; Sato K; Shiraishi N; Kitano S
Cancer; 2000 Oct; 89(7):1418-24. PubMed ID: 11013353
[TBL] [Abstract][Full Text] [Related]
12. Survival predictors in patients with node-negative gastric carcinoma.
Lee CC; Wu CW; Lo SS; Chen JH; Li AF; Hsieh MC; Shen KH; Lui WY
J Gastroenterol Hepatol; 2007 Jul; 22(7):1014-8. PubMed ID: 17608847
[TBL] [Abstract][Full Text] [Related]
13. Early gastric cancer: univariate and multivariate analysis for survival.
Tuech JJ; Cervi C; Pessaux P; Villapadierna F; Bergamaschi R; Ronceray J; Arnaud JP
Hepatogastroenterology; 1999; 46(30):3276-80. PubMed ID: 10626201
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of lymphatic invasion in patients with node-negative gastric cancer.
Ichikawa D; Kubota T; Kikuchi S; Fujiwara H; Konishi H; Tsujiura M; Ikoma H; Nakanishi M; Okamoto K; Sakakura C; Ochiai T; Kokuba Y; Otsuji E
J Surg Oncol; 2009 Aug; 100(2):111-4. PubMed ID: 19475584
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors of advanced gastric carcinoma without serosal invasion (pT2 gastric carcinoma).
Isozaki H; Fujii K; Nomura E; Mabuchi H; Nishiguchi K; Hara H; Tanigawa N
Hepatogastroenterology; 1999; 46(28):2669-72. PubMed ID: 10522062
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic study of advanced gastric cancer without serosal invasion in young and old patients.
Wang JY; Hsieh JS; Huang CJ; Huang YS; Huang TJ
J Surg Oncol; 1996 Sep; 63(1):36-40. PubMed ID: 8841464
[TBL] [Abstract][Full Text] [Related]
17. Relationship between hematogenic metastasis of gastric cancer and the maximum extent of venous invasion by cancer cells in the gastric wall.
Ikeguchi M; Katano K; Oka A; Tsujitani S; Maeta M; Kaibara N
Hepatogastroenterology; 1995; 42(5):660-5. PubMed ID: 8751231
[TBL] [Abstract][Full Text] [Related]
18. Significant prognostic factors in patients with node-negative gastric cancer.
Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H
Int Surg; 1999; 84(4):331-6. PubMed ID: 10667813
[TBL] [Abstract][Full Text] [Related]
19. [Lymph node metastasis and the extent of lymph node dissection for gastric cancer: report of 326 cases].
Wan Y; Pan Y; Liu Y; Wang Z; Ye J; Huang S
Zhonghua Wai Ke Za Zhi; 2000 Oct; 38(10):752-5. PubMed ID: 11832155
[TBL] [Abstract][Full Text] [Related]
20. Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker.
Wang CS; Wu TL; Tsao KC; Sun CF
Ann Clin Lab Sci; 2006; 36(1):23-30. PubMed ID: 16501233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
